NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

DRAFT

Questions

  • numbering didn't carry over well - Sharron to fix?
  • front page needs clickable index
  • do we need abstract from white paper? I'd like to remove, this page is long.
  • how to handle refrreferences (citations)?
  • remove refr references to other white paper sections and link to other file. Create links to sections or other items as appropriate.
  • images did not copy over - Sharron to help?
  • sample files in some of the images were not readable in the white paper and will be worse here
  • attach exemplars and link to themfront page needs clickable index
  • Is this content up to date?
  • how to handle glossary?
  • List team?
  • child pages are in alphabetical order - but there is a best order in approaching them. Perhaps rename so they appear in order? link that way in body of text and page navigation cues?

Abstract

The field of nanomedicine faces many challenges in the development of standards to support meaningful data submission and information exchange.  Numerous physico-chemical, in vitro, and in vivo assays must be addressed, with measurements currently dependent on non-standardized protocols and diverse technology types.  Representing Structure-Activity-Relationships (SARs) in nanomedicine, in particular, is critical to understanding the effects of nanomaterial structure on biological activity.  Unfortunately, information describing the nanomaterial including functionalizing entities and 3D structure is often represented in an undisciplined fashion.  This lack of standardization has been a significant deterrent to meaningful data sharing across the nanotechnology community; few publications contain sufficient information to enable adequate interpretation of results and successful achievement of experimental reproducibility.

...